Troy Brady
- Virology top 0.5%
- HIV Research and Treatment 6
- Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology 2
- HIV/AIDS drug development and treatment 2
- Genetics top 5%
- Virus-based gene therapy research 5
- Immunology top 10%
- T-cell and B-cell Immunology 2
- Oncology top 5%
-
- CRISPR and Genetic Engineering 8
- RNA and protein synthesis mechanisms 3
-
- Chromosomal and Genetic Variations 5
- Co-authors
- Frederic D. BushmanNirav MalaniCharles C. BerryShoshannah L. RothKaren E. OcwiejaGreg J. TowersTorsten SchallerLeo C. James
- Cited by
- VirologyInfectious DiseasesGenetics
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Troy Brady
17 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Virology 797
- Infectious Diseases 486
- Genetics 534
- Immunology 385
- Oncology 492
Countries citing papers authored by Troy Brady
This map shows the geographic impact of Troy Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Troy Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Troy Brady more than expected).
Fields of papers citing papers by Troy Brady
This network shows the impact of papers produced by Troy Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Troy Brady. The network helps show where Troy Brady may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Troy Brady, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 66 | |
| 2 | 2013 | 156 | |
| 3 | 2013 | 22 | |
| 4 | 2013 | 36 | |
| 5 | 2012 | 115 | |
| 6 | Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cellsbreakdown → | 2012 | 502 |
| 7 | 2011 | 55 | |
| 8 | 2011 | 55 | |
| 9 | 2011 | 177 | |
| 10 | 2011 | 375 | |
| 11 | 2009 | 89 | |
| 12 | 2009 | 121 | |
| 13 | 2008 | 18 | |
| 14 | 2008 | 36 | |
| 15 | 2007 | 57 | |
| 16 | 2007 | 14 | |
| 17 | 1988 | 2 |
About Troy Brady
Troy Brady is a scholar working on Virology, Infectious Diseases, Genetics, Molecular Biology and Immunology, having authored 17 papers that have together received 1.9k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (8 papers), HIV Research and Treatment (6 papers), Virus-based gene therapy research (5 papers), Chromosomal and Genetic Variations (5 papers), RNA and protein synthesis mechanisms (3 papers), Viral gastroenteritis research and epidemiology (2 papers), T-cell and B-cell Immunology (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Virology (797 citations), Infectious Diseases (486 citations), Genetics (534 citations), Immunology (385 citations) and Oncology (492 citations). Troy Brady has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Frederic D. Bushman, Nirav Malani, Charles C. Berry, Shoshannah L. Roth, Karen E. Ocwieja, Greg J. Towers, Torsten Schaller, Leo C. James, Una O’Doherty and Luis M. Agosto. Their work appears in journals such as PLoS Pathogens, Molecular Therapy, Human Gene Therapy, Molecular Cell and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.